We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IMUX market cap is 106.12M. The company's latest EPS is USD -1.0410 and P/E is -1.15.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -27.25M | -25.02M | -23.57M | -23.38M | -23.88M |
| Net Income | -25.27M | -24M | -22.77M | -21.57M | -29.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -37.03M | -48.97M | -91.67M | -119.49M | -99.22M |
| Net Income | -34.93M | -44.02M | -92.95M | -120.41M | -93.61M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 108.87M | 88.74M | 66.98M | 54.3M | 104.16M |
| Total Liabilities | 17.65M | 19.46M | 18.57M | 25.37M | 20.58M |
| Total Equity | 91.22M | 69.28M | 48.41M | 28.93M | 83.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 65.96M | 167.86M | 139.1M | 127.75M | 54.3M |
| Total Liabilities | 7.59M | 9.08M | 11.99M | 14.07M | 25.37M |
| Total Equity | 58.36M | 158.79M | 127.12M | 113.68M | 28.93M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.51M | -39.49M | -56.8M | -70.83M | -23.97M |
| Investing | 5.34M | 9.67M | 9.63M | 9.46M | -31k |
| Financing | 51k | 147k | 429k | 1.03M | 74.46M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -28.55M | -46.12M | -83.23M | -65.14M | -70.83M |
| Investing | 10.54M | -146k | -67k | -9.74M | 9.46M |
| Financing | 34.9M | 144.43M | 42.84M | 95.76M | 1.03M |
| Market Cap | 106.12M |
| Price to Earnings Ratio | -1.15 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.31 |
| Price to Book Ratio | 3.73 |
| Dividend Yield | - |
| Shares Outstanding | 89.93M |
| Average Volume (1 week) | 174.82k |
| Average Volume (1 Month) | 217.21k |
| 52 Week Change | -32.95% |
| 52 Week High | 3.11 |
| 52 Week Low | 0.9451 |
| Spread (Intraday) | 0.37 (23.87%) |
| Company Name | Immunic Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.imux.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
